An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies
Public ClinicalTrials.gov record NCT00226655. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302, NTI 0303, or Other Designated Studies
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to examine the long-term safety and tolerability of human corticotropin-releasing factor (hCRF), XERECEPT®, in patients requiring dexamethasone (Decadron) to treat peritumoral brain edema. This open-label, extended-use study is open to all patients who participate in either of the blinded studies, NTI 0302, NTI 0303, or other designated studies, including patients who may have discontinued blinded study medication early but completed the protocol-stipulated follow-up periods.
Study identification
- NCT ID
- NCT00226655
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 112 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2005 (Type not available)
- Primary completion
- Mar 2009 (Actual)
- Completion
- Apr 2009 (Actual)
- Last update posted
- Aug 31, 2012
2005 – 2009
United States locations
- U.S. sites
- 25
- U.S. states
- 13
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Barrow Neurological Institute | Phoenix | Arizona | 85013 | — |
| Hoag Memorial Hospital Presbyterian | Newport Beach | California | 92658 | — |
| Stanford University Medical Center | Palo Alto | California | 94305 | — |
| UC Davis Medical Center, Division of Medical Oncology | Sacramento | California | 95817 | — |
| UC San Diego Cancer Center | San Diego | California | 92037 | — |
| University of Colorado Cancer Center | Aurora | Colorado | 80045 | — |
| Colorado Neurological Institute Center for Brain & Spinal Tumors | Englewood | Colorado | 80113 | — |
| Mayo Clinic | Jacksonville | Florida | 32224 | — |
| Cancer Institute of Orlando | Orlando | Florida | 32804 | — |
| Moffitt Cancer Center | Tampa | Florida | 33612 | — |
| Winship Cancer Institute, Emory University | Atlanta | Georgia | 30322 | — |
| Feinberg School of Medicine, Northwestern University | Chicago | Illinois | 60611 | — |
| Evanston Northwestern Healthcare | Evanston | Illinois | 60201 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| Hermelin Brain Tumor Center, Henry Ford Hospital | Detroit | Michigan | 48202 | — |
| Dent Neurologic Institute | Amherst | New York | 14226 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10021 | — |
| Weill Medical College of Cornell University | New York | New York | 10021 | — |
| University Hematology Oncology Care, LLC | Cincinnati | Ohio | 43210 | — |
| Good Samaritan Hospital | Cincinnati | Ohio | 45220 | — |
| The Ohio State University | Columbus | Ohio | 43210 | — |
| Oregon Clinic | Portland | Oregon | 97210 | — |
| Virginia Mason Clinic | Seattle | Washington | 98111 | — |
| University of Wisconsin | Madison | Wisconsin | 53792 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226-3596 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00226655, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 31, 2012 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00226655 live on ClinicalTrials.gov.